Trademarkia Logo

Canada

C$
GRINDEX
REGISTERED

on 3 May 2024

Last Applicant/ Owned by

GRINDEKS AKCIJU SABIEDRIBA

Krustpils iela 53LV-1057 Riga

LV

Serial Number

2089149 filed on 13th Jan 2021

Registration Number

TMA1230981 registered on 3rd May 2024

Registration expiry Date

13th Jan 2031

Correspondent Address

AVENTUM IP LAW LLP

Suite 104, Tower A555 Legget DriveOttawa

ONTARIO

CA

K2K2X3

GRINDEX

Trademark usage description

chemical preparations for use in the manufacture of pharmaceuticals; chemicals for use in the pharmaceutical industry for preparing drugs and active p Read More

Vienna Information


5 . 5 . 19

Other flowers, blossoms -- Notes: (a) Including flowers or blossoms of trees (cherry trees, peach trees, apple trees) and of bushes. -- (b) Including flowers of protea and strelitzia.Autres fleurs -- Notes: (a) Y compris les fleurs d'arbres (cerisiers, pêchers, pommiers) et d'arbustes. -- (b) Y compris les fleurs de protea et de strelitzia.

5 . 5 . 20

Stylized flowersFleurs stylisées

5 . 5 . 21

One flowerUne fleur

Classification Information


Class [001]
Chemical preparations for use in the manufacture of pharmaceuticals; chemicals for use in the pharmaceutical industry for preparing drugs and active pharmaceutical substances, namely, preservatives for pharmaceutical preparations, chemical and diagnostic reagents for analysis, quality control, drug and active pharmaceutical production, sample preparation and extraction for use in pharmaceutical research laboratories and manufacturing facilities


Classification kind code

11

Class [003]
Cosmetics; functional cosmetics; cosmetic preparations for skin care.


Classification kind code

11

Class [005]
Pharmaceutical preparations for use in oncology; pharmaceutical preparations use in treating cardiovascular diseases; pharmaceutical preparations use in treating diabetes; pharmaceutical preparations use in treating central nervous system diseases and peripheral nervous system diseases; pharmaceutical preparations use in treating angina; pharmaceutical preparations use in treating ocular motility disorders; pharmaceutical preparations use in treating attention deficit hyperactivity disorder; pharmaceutical preparations use in treating the symptoms of Insomnia; pharmaceutical preparations used in treating neoplastic and immunomodulating diseases; pharmaceutical preparations use in treating musculoskeletal system diseases, namely, connective tissue disease, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations use in treating dermatological diseases, namely, dermatitis, skin pigmentation diseases, acne, eczema, psoriasis; pharmaceutical preparations use in treating sensory organ diseases; pharmaceutical preparations use in treating hormonal disorders; pharmaceutical preparations use in treating genitourinary system, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations use in gynecological diseases; pharmaceutical preparations use in treating infectious diseases, respiratory infections, eye infections, bacterial infections, viral infections, fungal infections, prion infections; pharmaceutical preparations use for regulating the immune system; antidopaminergic pharmaceutical preparations; vitamins and vitamin preparations, pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of gastrointestinal diseases; pharmaceutical preparations for the treatment of metabolic diseases; analgesics, anti-inflammatories, general anesthetics, antivirals; veterinary preparations use in treating hormonal disorders; veterinary preparations use in treating genitourinary system, namely, urological diseases, inflammatory pelvic diseases; veterinary preparations for use as a sedative; veterinary preparations for use as analgesics; veterinary preparations for use as muscle relaxants; veterinary preparation for use as anti-sedatives; veterinary preparation for use as anesthetics; veterinary preparation for use in treating cardiovascular diseases; Nutritional supplements consisting of vitamins and minerals, for the treatment of the musculo-skeletal system, namely, connective tissue diseases, cartilage injuries, immune support, central nervous system support, gastrointestinal and digestive support and for general health and well-being; dietary supplements for humans, namely, dietary supplements for humans for general health and well-being, dietary supplements for humans for enhancing the immune system, dietary supplements for humans for enhancing the gastrointestinal system, dietary supplements for humans for enhancing the nervous system, dietary supplements for humans consisting of vitamins, dietary supplements for humans consisting of micronutrients; Sanitary preparations for medical purposes, namely, antiseptics, hand sanitizing preparations, and sanitizing preparations for hard surfaces, antibacterial gels; adhesive tapes for medical purposes; vermin destroying preparations; fungicides; herbicides; vitamins and vitamin preparations.


Classification kind code

11

Class [035]
Advertising services to promote public awareness of medical conditions


Classification kind code

11

Mark Details


Serial Number

2089149

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 2th May 2022
Agent Changed
Submitted for opposition 256
on 4th Jan 2022
Notification of Possible Opposition Sent
Submitted for opposition 22
on 2th Nov 2021
Search Recorded
Submitted for opposition 20
on 2th Nov 2021
Examiner's First Report
Submitted for opposition 223
on 2th Nov 2021
Total Provisional Refusal
Submitted for opposition 257
on 4th Mar 2021
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 3rd Mar 2021
Formalized
Submitted for opposition 1
on 3rd Mar 2021
Created
Submitted for opposition 228
on 13th Jan 2021
International Registration
Submitted for opposition 30
on 13th Jan 2021
Filed